SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-24-013554
Filing Date
2024-02-12
Accepted
2024-02-12 06:06:38
Documents
1
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm245464d9_sc13g.htm SC 13G 72380
  Complete submission text file 0001104659-24-013554.txt   73983
Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

IRS No.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90491 | Film No.: 24617243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)